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Abstract
Introduction: In a previous study exploring central pain modulation with heterotopic stimuli in healthy volunteers, we found
that transitions between sustained noxious and innocuous thermal stimulations on the foot activated the ‘‘salience matrix’’.
Knowing that central sensory processing is abnormal in migraine, we searched in the present study for possible abnormalities
of these salient transitional responses in different forms of migraine and at different time points of the migraine cycle.
Methods: Participants of both sexes, mostly females, took part in a conditioned pain modulation experiment:
Migraineurs between (n¼ 14) and during attacks (n¼ 5), chronic migraine patients with medication overuse headache
(n¼ 7) and healthy volunteers (n¼ 24). To evoke the salience response, continuous noxious cold or innocuous warm
stimulations were alternatively applied on the right foot. Cerebral blood oxygenation level dependent responses were
recorded with fMRI.
Results: Switching between the two stimulations caused a significant transition response in the ‘‘salience matrix’’ in all subject
groups (effect of the condition). Moreover, some group effects appeared on subsequent post-hoc analyses. Augmented tran-
sitional blood oxygenation level dependent responses in the motor cortex and superior temporal sulcus were found in two
patient groups compared to healthy controls: chronic migraine with medication overuse headache patients and migraineurs
recorded during an attack. In chronic migraine with medication overuse headache patients, salience-related responses were
moreover greater in the premotor cortex, supplementary motor area, lingual gyrus and dorso-medial prefrontal cortex and
other ‘‘salience matrix’’ areas, such as the anterior cingulate and primary somatosensory cortices.
Conclusion: This study shows salience-related hyperactivation of affective and motor control areas in chronic migraine
with medication overuse headache patients and, to a lesser extent, in episodic migraine patients during an attack. The
greater extension of exaggerated blood oxygenation level dependent responses to unspecific salient stimuli in chronic
migraine with medication overuse headache than during a migraine attack could be relevant for headache chronification.
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ACC: anterior cingulate cortex; BOLD signal: blood
oxygenation level dependent signal; S1: primary som-
atosensory cortex; S2: secondary somatosensory cortex;
SMA: supplementary motor cortex; STS: superior tem-
poral sulcus; HV: healthy volunteers; MnA: interictal
episodic migraine patients; MA: episodic migraineurs
during an attack; CM-MOH: chronic migraine with
medication overuse headache.
Background
While episodic migraine is characterized by recurrent
attacks separated by symptom-free intervals, its com-
plication, chronic migraine (CM), produces quasi daily
headache and is most frequently favoured by overuse of
acute migraine drugs causing so-called medication
overuse headache (MOH) (1).
Headache chronification may involve an impairment
of central pain control mechanisms. Cortical processing
of painful stimuli is altered in CM patients (2) who also
have hyper-excitability of sensory cortices to innocuous
stimuli (3). The cerebral network previously termed the
‘‘pain matrix’’ (4) includes the anterior cingulate cortex,
insula, SI, SII, medial temporal cortex and prefrontal
cortex. In fact, besides being activated by noxious sti-
muli, these areas also respond to highly salient innocu-
ous stimulations (5), hence the rewording in ‘‘salience
matrix’’.
Migraine patients have increased connectivity of
‘‘salience matrix’’ regions (anterior insula and anterior
and mid-cingulate cortex) with other brain areas (6).
It has been suggested that enhanced engagement of
the salience network in migraine patients results in
impaired ability to disengage attention from ongoing
pain (7). Brain activations by noxious and innocuous
stimuli between and during migraine attacks were
found to be abnormal in a number of studies compre-
hensively reviewed by Schwedt et al. (8). In migraine
patients compared to healthy controls, interictal
pain-induced activations were greater in the dorsolat-
eral prefrontal cortex, temporal pole, postcentral gyrus,
anterior and middle cingulate cortex, hippocampus,
parahippocampal gyrus and lentiform nuclei, but smal-
ler in the precentral gyrus, secondary somatosensory
cortex and superior temporal gyrus. Stimulus-induced
activation is more pronounced during than outside of
an attack in the insular cortex, temporal pole, occipital
cortex, parahippocampal gyrus, posterior thalamus or
amygdala, depending on sensory modality.
In MOH, functioning of various areas belonging to
the ‘‘salience matrix’’ including the insula, posterior
parietal lobe, orbitofrontal cortex and thalamus was
altered (9). Mechanical pain-induced fMRI BOLD
activation was reduced in several areas of the lateral
pain system such as the parietal cortex and supramargi-
nal gyrus (10). Morphometric MRI studies showed
decreased gray matter volume (11) and reduced thick-
ness in the orbitofrontal cortex, but higher local gyrifica-
tions in temporal and occipital cortices (12). Functional
connectivity at rest in MOH patients was decreased
between the precuneus and regions of the default-mode
network (frontal and parietal cortices), but increased
between the precuneus and hippocampal/temporal
areas (13).
We have previously shown in healthy volunteers that
switching between noxious and innocuous sustained
thermal stimuli induces a widespread nonspecific acti-
vation of the ‘‘salience matrix’’ areas (14). In the pre-
sent study, we investigated with fMRI whether this
salience response is abnormal in migraine patients
between and during attacks, and in MOH patients.
Materials and methods
Subjects and experimental protocol
The healthy volunteers and migraine patients aged 18–
65 years were recruited from the personnel of Centre
Hospitalier Régional de la Citadelle, Liège, Belgium,
and students of the University of Liège, Belgium. The
project was registered with EudraCT and the Belgian
Federal Agency for Medicines and Health Products
(B70720084343) and was approved by the Ethics
Committee of the University Hospital (Liège,
Belgium) (ref 2008/160). Twenty-four healthy male
and female volunteers (mean age: 31.3 years, range:
24–45 years) took part in the experiment (HV group).
None of the healthy subjects had a chronic pain, neuro-
logical or psychiatric disorder.
A structured interview allowed identification of
migraine patients according to the criteria of ICHD-
II: Codes 1.1, 1.3 and 8.2 (1). The criteria of inclusion
comprised age, the ability to speak French, not being
on antidepressant (tricyclic or SSRI) treatment and not
taking prophylactic antimigraine treatment. Subjects
with cognitive impairments or major handicap, cerebral
hypertension or previous cerebral trauma, language dif-
ficulties, alcoholism, cancer or contraindication for an
MRI scan were not included in the study. After recruit-
ment for the study, MOH patients diagnosed according
to ICHD-II criteria filled in a paper headache diary for
at least 1 month to document headache and medication
overuse before undergoing the recordings. We recorded
14 episodic migraine without aura patients (four males,
mean age: 32.8 years, range 18–47 years) outside of an
attack (interictal: 3 days after and before an attack)
(MnA group), five patients during an attack (ictal, one
male, mean age 33.6 years, range 20–58 years) (MA
Bogdanov et al. 989
group) and seven female patients suffering from chronic
migraine with medication overuse headache (CM-MOH,
mean age 44.4 years, range 24–60 years). The ongoing
headache intensity during fMRI recordings was esti-
mated using a visual analogue scale from 0 to 10.
All subjects signed an informed consent form. They
were only aware of the general purpose of our experi-
ment; that is, study of the impact of cold on pain and
physiological responses induced by laser heat stimuli.
They were thus naı̈ve about our working hypothesis.
Healthy subjects received a financial compensation for
their willingness to participate in the study and the time
spent in the laboratory. Patients were paid for their
travel expenses.
The experimental protocol was the same as in
our previous study (14). We aimed to test the effect of
heterotopic noxious conditioning on phasic test pain
responses; that is, a central pain modulation mechan-
ism that is impaired in chronic pain. Laser heat stimuli
on the left hand were combined with continuous
noxious cold alternating with innocuous lukewarm
stimulations applied using compresses on the right
foot. In the present study we focused on the cerebral
responses to the heterotopic conditioning stimulation.
There were 10 blocks of noxious cold (120ms each) and
10 blocks of innocuous warm stimulation (100ms
each). The pain levels were controlled as in our previ-
ous study (14). Analysis of pain level data did not
reveal any relation with other results, and they will
not be discussed herein.
The Cogent 2000 software delivered auditory stimuli
to the operator who stayed all the time in the scanning
room next to the subject, informing him when to manu-
ally replace the compresses (Cogent 2000 developed by
the Cogent 2000 team at the FIL and the ICN and
Cogent Graphics developed by John Romaya at the
LON at the Wellcome Department of Imaging
Neuroscience).
Structural and functional MRI data acquisition
MRI data were acquired on a 3T head-only scanner
(Magnetom Allegra, Siemens Medical Solutions,
Erlangen, Germany) using a standard transmit-receive
quadrature head coil.
A structural MRI was acquired in a separate session
20–30 minutes before the functional acquisition. For the
structural scan, a high-resolution T1-weighted image
was obtained for each subject (3D MDEFT (15);
TR¼ 7.92ms, TE¼ 2.4ms, TI¼ 910ms, FA¼ 15,
FoV¼ 256 256 176mm3, 1mm isotropic spatial
resolution, 176 sagittal slices, 1mm thickness, acquisi-
tion time: 12 minutes).
Multislice T2*-weighted functional images were
acquired with a gradient-echo echo-planar imaging
sequence using an axial slice orientation and covering
the whole brain/most of the brain (34 slices, FoV¼
192 192mm2, voxel size 3 3 3mm3, 25%
interslice gap, matrix size 64 64 34, TR¼ 2040ms,
TE¼ 30ms, FA¼ 90). The three initial volumes were
discarded to avoid T1 saturation effects.
Field map data were also acquired to unwarp the
functional images: Acquisition time: TR/TE: 517/4.92
and 7.38ms, Resolution: 64 64, Slices: 32 slices (3mm
thickness, 30% gap), Voxel size: 3.4 3.4 3mm3; FoV:
220 220 mm2, FA: 90, Bandwidth: 260Hz/Px.
sMRI and fMRI data analysis
The fMRI images were processed using the ‘‘Statistical
Parametric Mapping’’ software (SPM8; Wellcome Trust
Centre for Neuroimaging, University College London,
UK; http//www.fil.ion.ucl.ac.uk/spm) implemented in
MATLAB (Mathworks Inc., Sherborn, MA).
Functional image time series were corrected for
motion and distortion using the ‘‘Realign and
Unwarp’’ tool (16) together with the Fieldmap
Toolbox (17). The high-resolution T1 image was then
co-registered with the functional images and segmented
into grey matter, white matter, and cerebrospinal fluid
(18). Functional images were spatially normalized to
the Montreal Neurological Institute (MNI) space
(voxel size: 3 3 3 mm2) using the normalization par-
ameters obtained from the segmentation procedure
and, subsequently, smoothed with a Gaussian kernel
with full-width at half-maximum of 6mm.
Statistical analysis was performed using a general
linear model and summary statistics approach. At the
first level, data were subjected to high-pass filtering
using a cut-off period of 280 seconds. Each boxcar or
impulse stimulus function was convolved with a canon-
ical hemodynamic response function as implemented in
SPM8. Explicit masks were created from the brain
mask image available in SPM8. The binary mask was
created by thresholding the brain mask image at a level
of 0.5 intensity units. This mask fitted the average nor-
malized anatomical image of our subject group well.
The first 10 s after switching from warm to cold or
from cold to warm were modelled as ‘‘early’’ response.
This was used in other studies (19) and allowed good
differentiation between early and continuous phase
responses. After model estimation, specific effects
were tested with appropriate linear contrasts of the par-
ameter estimates, resulting in a contrast value for each
voxel. We computed the contrast for early nonspecific
responses to transitions between warm and cold appli-
cations on the foot.
The contrast images were included in a second-level
group analysis using a random-effects approach,
treating inter-subject variability as a random factor.
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First, at the second level, we performed an omnibus
F-test for detection of overall transition response
within four groups.
Then we used an F-test with a contrast for one-way
ANOVA to estimate any group effects. We used an
undirected search, looking for responses with p< 0.05
family wise error rate (FWER) corrected for the whole
brain volume both at the voxel and cluster levels.
Voxel-level significant responses were p< 0.05 FWER
corrected, while cluster level significance was computed
under p< 0.001 uncorrected cluster-forming threshold.
The direction of the group effect was verified by spe-
cific post-hoc t-tests with contrasts for the difference
between HV and patient groups where the major dif-
ference of the contrast estimates was observed.
Since the greatest post-hoc group effects were found
in CM-MOH versus HV contrast, we verified if the areas
of maximal overall transition response (S1, insula, thal-
amus and ACC) showed differential activation along
with areas yielded by undirected search. In order to
verify if there was an effect with minimal correction,
we applied inclusive masks of respective cerebral areas
to the t-contrast HV<CM-MOH with cluster forming
threshold p< 0.001, and estimated both peak and cluster
significance of the effect.
Head displacement analysis
Head displacements can reflect motor reactions induced
by the compress replacement during the scanning pro-
cedure and were computed at realignment of functional
scans obtained during the whole scanning session.
Time series of the sagittal motion parameter estimated
by SPM at realignment of functional images were
1000Hz interpolated and partitioned in 10 sec bins
locked accurately to the transition time. Within each
bin, peak-to peak displacements was calculated. We
segregated displacements occurring during the first 10
seconds after changing from cold to warm compress or
vice versa and those occurring during the following 90
seconds of sustained cold or warm stimulation. Within-
subject average displacements were compared between
four groups of subjects and the significance of group
effect was calculated with the Multiple Comparisons
(2-tailed) Kruskal-Wallis test.
Results
Switching between noxious cold and innocuous
warm sustained foot stimulation or vice versa induced
a short-lasting but widespread BOLD response in
all groups of subjects that was maximal in the somato-
sensory cortex (Figure 1). The activation by the stimu-
lation switch was a non-specific salience response, and
it did not differ between the transition from noxious
cold to innocuous lukewarm and the inverse transition
(Figure 1). Besides S1, the posterior insula/S2, thal-
amus and anterior cingulate cortex were other areas
activated by the transition. The ‘‘salience’’ response
in brain regions belonging to the ‘‘salience matrix’’
was significant in all subject groups (p< 0.05 FWE)
(Figure 2).
However, in MA and CM-MOH patients, this acti-
vation was significantly greater in many other brain
areas, mostly on the left side of the brain (Table 1,
Figure 3). The effect did not differ between responses
to onset or offset of cold (Figure 3).
There were a number of frontal, occipital and tem-
poral areas where a significant group effect was found
(Table 1, Figure 4). Post-hoc test confirmed that in
WarmCold




















Figure 1. Average hemodynamic response in somatosensory cortex S1 (shown in the right upper corner) to warm/cold and cold/
warm transitions in all subjects (n¼ 50). The BOLD signal was extracted from a 6 mm radius spherical VOI at [15 46 64] MNI (blue
circle of statistical parametric map in insert). Eigenvariates were normalized to the median value of an individual time series, epoched
and individually averaged for cold (left) and lukewarm (right) conditions and the group average was estimated (spline interpolation
1000 Hz, low pass filtering 10 Hz).
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Table 1. Cerebral areas with a group effect in cerebral activation during transition between warm and cold or vice versa. ANOVA
results are shown on the left and post-hoc t-tests for respective areas on the right. Different patterns of group effect are indicated by
colors: Red (HV, MnA)< (MA, CM-MOH), yellow (HV, MnA, MA)<CM-MOH and green HV<MnA<MA<CM-MOH. Post-hoc
peaks belonging to the same STS cluster are labeled respectively with indexa; *p< 0.05 whole brain FWER corrected, either voxel or






FWER p< 0.05 kE
CM-MOH>HV
contrast
FWER p< 0.05 kE
Threshold
FWER p< 0.05
1. Temporo-occipital (STS) [51 55 13]* 11 [51 49 10]* 1 [51 55 13]* 36a
2. Temporo-occipital (STS) [42 49 13]* 3 [42 49 13]* 36a
3. M1/premotor [36 4 46]* 2 [36 4 46]* 3
4. Premotor [39 5 31]* 5 [39 5 31]* 48
5. Premotor [48 5 19]* 1 [48 5 19]* 23
6. SMA/dorsal ACC [9 26 49]* 6 [9 26 49]* 42
Threshold
p< 0.001 uncorrected
Temporo-occipital (STS) [48 52 10] 249*
Lingual gyrus [21 58 2] 378* [24 58 2]* 20
Dorso-medial PFC [12 41 31] 159* [12 41 31]* 7
Middle occipital gyrus [30 76 7] 140*
Anterior STS [45 1 20] 67*
Putamen [33 4 8] 86*
Transition-induced activation across groups
Insula Thalamus ACC
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HV MnA MA CM-MOH
Design matrix
Figure 2. Noxious-innocuous transition-induced activation of salience matrix areas in healthy volunteers (HV), migraine patients
between attacks (MnA) and during an attack (MA), and in patients suffering from chronic migraine with medication overuse headache
(CM-MOH). Upper: statistical parametric maps overlaid on a sagittal section of averaged individual normalized structural T1 images;
crosshairs indicate peak activations in S1, insula, thalamus and anterior cingulate cortex. Lower: contrast estimates (90% CI) of the
local statistical peak. x, y and z coordinates according to MNI space.
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[–36, –4, 46] [–21, –58, –2] [30, –76, 7] [33, –4, –8]
[–39, 5, 31] [9, 26, 49] [45, –1, –20]
Height threshold F = 6.4 {p<0.001 (unc.)}
STS
M1/premot. Lingual gyrus Middle occipital gyrus Putamen
Premotor cortex SMA Anterior STS
Figure 4. Regional transition-induced activation BOLD responses in the four subject groups. Both migraine patients during an attack
(MA) and chronic migraine patients with medication overuse headache (CM-MOH) have increased responses in the posterior superior
temporal sulcus (STS) and M1. In the premotor cortex and lingual gyrus the increased response is only found in the CM-MOH group,
while in the SMA, anterior STS, middle occipital gyrus and putamen there is a progressive increment of the BOLD response along the
sequence HV<MnA<MA<CM-MOH. For the images, p< 0.001 uncorrected threshold has been used.
Migraine ictal
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Figure 3. BOLD response to cold/warm transitions in the motor cortex (VOI shown in the left) in migraine patients interictally
(n¼ 14, blue line) and during an attack (n¼ 5, red line). The BOLD signal was extracted from a 48 voxel cluster identified with a t-test
(HV<MA) highlighted with blue contour on statistical map on the right inset (signal processed as in Figure 1).
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migraine patients during an attack (MA), the transition
response was greater in the left motor cortex and left
posterior superior temporal sulcus compared to healthy
volunteers (Table 1, Figure 4). By contrast, there was
no significant difference in transitional BOLD activa-
tions between interictal migraine patients (MnA) and
healthy controls.
In CM-MOH patients, the transitional salience
response was also greater than in healthy volunteers
in the motor cortex and in the superior temporal
sulcus, like in ictal migraine. In addition, in CM-
MOH patients there was an increase in activity of the
left and right premotor cortex, supplementary motor
area, anterior cingulate cortex (ACC), left lingual
gyrus and dorso-medial prefrontal cortex (Table 1,
Figure 4). ANOVA also revealed increased activation
in the middle occipital gyrus, anterior superior tem-
poral sulcus and putamen.
The hyperactivation of S1, insula, thalamus and
ACC by switching between cold/warm stimulation
was confirmed in CM-MOH patients at the cluster
level by inclusive anatomical masking (Table 2,
Figure 5).
We found no correlation between fMRI BOLD data
and headache intensity during the recordings in MA or
CM-MOH subjects.
To search for differences in head movements during
the experimental procedure, the head motion param-
eters were extracted from the realignment parameters
estimated by the SPM software. The between-group
effect was significant during the 90-second period of
sustained cold or warm application, but not during
the early response. CM-MOH patients disclosed greater
head displacements than healthy volunteers. We found
no significant difference in head motion between
migraine patients during an attack and healthy volun-
teers at any time point (Figure 6).
Discussion
We found significant early non-specific ‘‘salience’’
BOLD responses at the onset and offset of noxious
cold or innocuous lukewarm stimulation (cold/warm
transition) in healthy subjects, which is concordant
with our previous findings (14), but also in migraine
patients during and outside of an attack, and in
patients suffering from chronic migraine with medica-
tion overuse headache (CM-MOH). These responses
T-contrast
T-score S1 inclusive mask Insula inclusive mask
Tranistion- induced activation, group effect HV < CM-MOH
Thalamus inclusive mask ACC inclusive mask































































Contrast estimates and 90% C.I.
[18, –34, 67] [–51, –7, 22] [–36, –10, –8] [18, –28, 1] [–6, 35, 22]
Figure 5. Increased transition-induced activation responses in chronic migraine patients with medication overuse patients (CM-
MOH) in masked ‘‘salience matrix’’ areas. For the images, p< 0.001 uncorrected cluster forming threshold has been used. See detailed
description in the Methods section.
Table 2. Inclusive masking of the t-test HV<CM-MOH based
on the omnibus ANOVA peaks. p< 0.001 cluster-forming
threshold used. *p< 0.05 whole brain FWER corrected, either
voxel or cluster level, depending on whether coordinates or
cluster size value kE is labeled.
Area/mask MNI peak coordinates kE




Insula [30 17 5]*
[36 10 8]*
160*
Thalamus [18 28 1] 151*
ACC [6 35 22] 200*
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were observed in a number of cortical and subcortical
areas belonging to the ‘‘salience matrix’’. The main
novel finding was that during migraine attacks, and
even more so in CM-MOH patients, the transitional
salient activation was significantly augmented in certain
areas, while this was not the case in migraine patients
between attacks. We will discuss the possible patho-
physiological significance of these findings in interictal
and ictal migraine, and thereafter in CM-MOH.
There is clear evidence of altered noxious processing
in migraine (8,20); however, in our study, the transi-
tional responses differ only for ictal migraine patients.
This could be related to the fact that the transition
between noxious and innocuous stimuli in our para-
digm represents short-lasting sensory information of
a quite different nature compared to that generated
by the stimuli used in pain-activation and evoked



















































































Figure 6. Motion in the scanner in mm estimated from the sagittal head displacement. (a) Individual example of head motion
recorded in the scanner over 200 seconds and peak-to-peak displacements during 10-second bins. (b) 95% confidence interval (CI) of
average peak-to-peak head displacements during cold and warm stimulation. CI is computed by median bootstrap with 104 iterations.
(c) Median values of peak-to-peak displacement during 10-second transitions and 90-second sustained stimulations. Groups: HV,
healthy volunteers (n¼ 24); MnA: migraine patients between attacks (n¼ 14); MA: migraine patients during an attack (n¼ 5), and
chronic migraine patients with medication overuse headache (CM-MOH) (n¼ 7).
*p< 0.05 by Multiple Comparisons (2-tailed) Kruskal-Wallis test. 95% is computed as in (b).
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being salient, may not be sufficiently potent to reveal
an increased responsivity of the ‘‘salience matrix’’ in
migraine between attacks.
Both ictal migraineurs (MA) and CM-MOH patients
had increased unspecific transitional BOLD responses
in the motor cortex and superior temporal sulcus.
Increased connectivity within several brain networks
including motor cortex were observed in migraine
patients during an attack (21). Besides that, in magne-
toencephalography studies, abnormal cortical excitabil-
ity is found in migraine patients during the attack (22).
These data are in line with the over-reactivity of the
motor cortex in our study.
The superior temporal sulcus is a multimodal con-
vergent brain area responsible for multisensory integra-
tion due to its bidirectional connections with auditory,
visual, and somatosensory cortices and multisensory
neurons. It is also known to be activated by affective
pain aspects during the watching of painful scenes (23).
Though this area was shown to be hypoactivated in
migraineurs between attacks (8), its activation during
an attack or in chronic migraine may explain both the
multimodal hypersensitivity that accompanies the
migraine attack rendering patients intolerant to various
sensory inputs (24) and the affective symptoms (25).
Unlike migraineurs during an attack, CM-MOH
patients also displayed overactivation to cold/warm
switches in the left lingual gyrus, dorso-medial premotor
cortex and supplementary motor area (SMA) and thal-
amus (Figure 4).
The lingual gyrus is a part of the occipital cortex with
a significant role in vision and memory. In migraine
patients, this region may be involved in the generation
and propagation of the migraine aura (26). Light stimu-
lation-induced activation was stronger in the secondary
visual cortex, corresponding to the lingual gyrus region,
in migraine patients, which mirrors the effect of con-
comitant pain and light stimulation in controls (27).
Increased lingual gyrus activation in CM-MOH patients
in our study may be a reflection of increased visual
cortex sensitization in the distressing context of chronic
migraine headache.
The supplementary motor area and adjacent motor/
premotor cortices, involved in memorizing the dynamic
aspects of repeated pain, are overactivated in migraine
patients in response to painful stimuli (28). This is in
line with our findings in CM-MOH patients. A possible
cause of the augmented SMA activity in CM-MOH
patients may also be an increased demand of motor
control. During the scanning sessions, all subjects
were requested to avoid movements. The analysis of
head movements during the neuroimaging recordings
showed that CM-MOH patients moved significantly
more than the other subjects. We have reported the
data on head movements in the scanner that is usually
considered of no interest to confirm that the difference
between CM-MOH and the other groups cannot be
attributed to motion artefacts. There are several rea-
sons why the different salience-related brain activity
between groups is unlikely to be due to head motion.
First of all, the motion parameters are included in the
fMRI analysis as covariates of no interest, so their
impact is not considered in the BOLD response. With
regards to the whole brain map, the localization of
motion-induced activity is mostly at the edges between
the tissues: the surface of the brain and white matter-
ventricle transitions. Greater activity in CM-MOH and
MA groups is, on the contrary, located mostly in the
cortical grey matter; that is, not in locations typical for
motion-related artefacts. As shown in Figure 6, head
motion is numerically greater in CM-MOH patients
than in the other groups during all conditions, but this
difference is significant during sustained cold and warm
applications and not during transitions. It can therefore
not explain the specific BOLD changes that only occur
at the cold-warm and warm-cold transitions.
The hyperactivation of the SMA that plays a key
role in motor control, particularly in the control of
internally generated movements and postural body sta-
bilization, may reflect increased mobilisation of brain
resources to maintain the same position for a long time.
Increased necessity of self-control in CM-MOH
patients during the cold/warm switch may be also
reflected by the augmented BOLD responses in the pre-
frontal cortex. It is known that the superior frontal
gyrus is involved in introspection (29). Specific activa-
tion in this area in CM-MOH supports our hypothesis
that SMA/premotor activation can be due to increased
self-focusing due to the experimental paradigm.
Greater activation of the motor cortex in CM-MOH
may be related to the role of the motor cortex in des-
cending antinociceptive controls, which are known to
be compromised in this patient cohort and could be in
line with the well-documented analgesic effect of motor
cortex stimulation in chronic pain syndromes (30).
At first sight, cerebral nonspecific overactivation
in CM-MOH may seem surprising given that most
metabolic and morphometric studies have shown
respectively hypometabolism and a decrease of grey
matter density or cortical thickness in such patients
(9–11,31). Nonetheless, several evoked potential studies
in CM-MOH patients indicate hypersensitivity of
somatosensory cortices to innocuous (32) or noxious
stimuli (33). With migraine chronification, the sensory
cortices become truly hyperexcitable, which contrasts
with their relative hypoexcitability to single stimuli,
but hyperresponsivity to repeated stimuli, in episodic
migraine between attacks (32,34). Whether this could
be related to functional changes in the thalamus
where increased tissue volume, including of sensory
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nuclei, was reported in CM-MOH patients (35,36)
remains to be determined. The electrophysiological
profile in chronic migraine thus resembles that of the
migraine attack (37), but switches to the interictal pat-
tern when chronic migraine reverses to episodic
migraine after adequate treatment (38).
A morphological correlate of cortical hypersensitivity
in CM-MOH could be the recent finding of higher local
gyrifications in temporal and occipital cortices (12).
To test further the cerebral overactivation in
CM-MOH patients, and since the greatest post-hoc
group effects were found between the CM-MOH and
HV groups, we applied an inclusive mask analysis
(Figure 5). This approach demonstrated in CM-MOH
patients an overactivation of the ACC, thalamus, insula
and S1; that is, brain areas belonging to the ‘‘salience
matrix’’, previously called the ‘‘pain matrix’’ (4,5).
Activity in these areas correlates with unpleasant-
ness, intensity and affective components of pain percep-
tion and depends on other factors like attention, mood
and actual situation. This network is also activated by
non-painful stimuli as long as they are highly salient.
Our results corroborate this concept, since the highly
salient switching from warm to cold or from cold to
warm induced widespread responses in areas of the
‘‘salience matrix’’ irrespective of the direction of the
switch.
Our findings suggest that overall salience reactivity is
enhanced during migraine attacks, and even more so in
chronic migraine with medication overuse headache.
Enhanced engagement of the salience network (7) and
increased connectivity of two of its core regions, the
anterior insula and anterior cingulate cortex, with
other brain areas has already been reported in migraine
patients (6), and increased grey matter density was found
in the anterior cingulate cortex for the ‘‘in pain’’ phase
compared with the interictal period (39).
Hyperreactivity in salience-related brain regions in
ictal migraine, and to an even higher degree in CM-
MOH patients, may reflect a general hypersensitivity
to external stimuli or enhanced expectation towards
salient events. Whether this hypersensitivity promotes
the headache and correlates with allodynia or is facili-
tated by the pain remains to be determined.
Although we cannot rule it out formally, the possibil-
ity that the increased ‘‘salience responses’’ in CM-MOH
patients could be consequent to an enhanced transmis-
sion of thermonociceptive input at spinal level is unlikely
for various reasons. First, the fact that we found no cor-
relation between pain perception and fMRI data in this
study does a priori not favour a bottom-up mechanism
related to increased activity in nociceptive pathways at
the spinal or subcortical level. Concordantly, in a study
of trigeminal nociception in CM-MOH patients,
responses to noxious stimuli were chiefly increased cen-
trally and not at the brain stem level (33). Second, in
CM-MOH we found no significant increase in BOLD
responses during sustained cold application or instant-
aneous noxious laser stimulation. It is nonetheless note-
worthy that in our study CM-MOHpatients, but not the
other subjects, reported pain from application of luke-
warm compresses, which suggests that they were allody-
nic even at an extracephalic site.
Headache intensity during the experimental session,
on the other hand, did not impact the fMRI results
in CM-MOH patients (data not shown), suggesting
that the large saliency-related overactivation in multiple
brain areas found here is not related to ongoing head
pain. Admittedly, the VAS used to assess headache inten-
sity during the recordings may not be reliable or sensitive
enough to detect weak correlations. In our study there
was an incremental activity change between groups
along the sequence (healthy volunteers< interictal
migraine< ictal migraine<CM-MOH) in the SMA,
middle occipital gyrus, anterior STS, putamen and
insula. It remains to be determined whether this might
be related to headache frequency and/or chronification.
Our study has some limitations. The low number of
patients in the MA and CM-MOH groups is one of
them. It is notoriously difficult to recruit migraine
patients for imaging studies during spontaneous attacks
and during the chronic disabling phase of their disease.
We think, however, that these limitations are out-
weighed by the fact that we were able to record cerebral
responses of migraine patients during the attack and in
the chronification phase with medication overuse and
to compare them with those of patients in the interictal
phase and healthy volunteers. The comparison revealed
highly significant differences between groups. In spite of
our groups not being equilibrated with respect to age,
and the CM-MOH patients being significantly older
than the controls, our supplementary analysis revealed
that there is no trend in covariation between age and
the activation of the areas of interest in the controls,
therefore we suggest that age uniquely cannot explain
salience-related hyperactivity in MOH.
To conclude, BOLD responses to unspecific salient
stimuli are increased in multisensory brain areas
belonging to the ‘‘salience matrix’’ and in certain
motor areas during migraine attacks and in a broader
network of affective and cognitive cerebral areas in
chronic migraine patients with medication overuse.
This suggests that increased responsivity to salient sen-
sory stimuli may play a crucial role in migraine head-
ache and its chronification, and headache-associated
sensoriphobia as well as possibly allodynia.
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Article highlights
. Transitions between noxious and innocuous stimuli activate the ‘‘salience matrix’’ areas of the brain.
. BOLD responses to such transitions were recorded in patients with migraine at headache-free and attack
phases and in chronic migraine with medication overuse headache.
. Over-activations of affective, motor control and ‘‘salience matrix’’ areas are observed in the two last patient
groups.
. The greater BOLD responses to unspecific salient stimuli could be relevant for headache chronification.
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